Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$25.40 USD
-0.14 (-0.55%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $25.35 -0.05 (-0.20%) 7:52 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, Anika Therapeutics (ANIK) reported earnings of -$4.30 per share, missing the Zacks Consensus Estimate of -$0.26 per share. This reflects a negative earnings surprise of #######%. Look out for ANIK's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 73.24%.
Earnings History
Price & Consensus
Zacks News for ANIK
Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Tops Revenue Estimates
ANIK: What are Zacks experts saying now?
Zacks Private Portfolio Services